Back to search

Article

5β-Dihydrotestosterone and mutant androgen receptor vulnerability in prostate cancer

2026-07-30

Abstract excerpt

<title>Abstract</title> <p>BACKGROUND Bipolar androgen therapy (BAT) exploits the paradoxical vulnerability of castration-resistant prostate cancer (CRPC) to supraphysiologic androgen. However, testosterone (T) is used clinically for BAT, which broadly activates wild-type androgen receptor (AR) in normal androgen-responsive tissues and can cause substantial systemic androgenic effects. 5β-Dihydrotestosterone (5β...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21e4f3d1-91ae-570a-be05-1dc489c66f38
DOI
10.21203/rs.3.rs-10462224/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
5β-Dihydrotestosterone and mutant androgen receptor vulnerability in prostate cancerDOI 10.21203/rs.3.rs-10462224/v1
Select a neighboring publication to make it the new centre.